See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Thalia Field

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36773014	0	Krzywicka K, Aguiar de Sousa D, Cordonnier C, et al. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur J Neurol. 2023 Feb 11. doi: 10.1111/ene.15735.
	36337058	0	Zhou LW, Yu AYX, Ngo L, et al. Incidence of Cerebral Venous Thrombosis: A Population-Based Study, Systematic Review, and Meta-Analysis. Stroke. 2022 Nov 7. doi: 10.1161/STROKEAHA.122.039390.
	36212651	0	Heldner MR, Aguiar de Sousa D, Field TS, et al. Editorial: Cerebral venous thrombosis. Front Neurol. 2022 Sep 23;13:1021547. doi: 10.3389/fneur.2022.1021547. eCollection 2022.
	36082668	0	van de Munckhof A, Lindgren E, Kleinig TJ, et al. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke. 2022 Sep 9:101161STROKEAHA122039575. doi: 10.1161/STROKEAHA.122.039575.
	35938419	0	Yaghi S, Saldanha IJ, Misquith C, et al. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke. 2022 Aug 8:101161STROKEAHA122039579. doi: 10.1161/STROKEAHA.122.039579.
	35689346	0	Scutelnic A, Krzywicka K, Mbroh J, et al. Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26431.
	35677980	0	Nguyen TN, Qureshi MM, Klein P, et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J Stroke. 2022 May;24(2):256-265. doi: 10.5853/jos.2022.00752. Epub 2022 May 31.
	35611694	0	Chang SJ, Rebchuk AD, Teal P, et al. COVID-19-Associated Cerebral Developmental Venous Anomaly Thrombosis With Hemorrhagic Transformation. Stroke. 2022 May 25:101161STROKEAHA122039534. doi: 10.1161/STROKEAHA.122.039534.
	35491501	0	Sposato LA, Field TS. Atrial fibrillation detection after stroke: Is all created equal? Eur J Neurol. 2022 Jul;29(7):1869-1870. doi: 10.1111/ene.15375. Epub 2022 May 8.
	35201292	0	Lee AY, Al Moosawi M, Peterson EA, et al. Clinical Care Pathway for Suspected Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 vaccination. Blood Adv. 2022 Feb 24. pii: 484151. doi: 10.1182/bloodadvances.2021006862.
	35143324	0	Gorman JB, Field TS. ACTION-CVT: Are the Findings ACTIONable? Stroke. 2022 Feb 10:STROKEAHA122038564. doi: 10.1161/STROKEAHA.122.038564.
	35100023	0	Rivard L, Friberg L, Conen D, et al. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31.
	35028817	0	Alimohammadi A, Kim DJ, Field TS. Updates in Cerebral Venous Thrombosis. Curr Cardiol Rep. 2022 Jan 13. pii: 10.1007/s11886-021-01622-z. doi: 10.1007/s11886-021-01622-z.
	34921078	0	Nasreen S, Calzavara AJ, Sundaram ME, et al. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open. 2021 Dec 17;11(12):e052019. doi: 10.1136/bmjopen-2021-052019.
	34645539	0	Zhou LW, Yu AYX, Hall W, et al. Validity of ICD 10 Codes for Cerebral Venous Thrombosis Depends on Clinical Context. Can J Neurol Sci. 2021 Oct 14:1-10. doi: 10.1017/cjn.2021.235.
	34581763	0	Sanchez van Kammen M, Aguiar de Sousa D, Poli S, et al. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021 Sep 28. pii: 2784622. doi: 10.1001/jamaneurol.2021.3619.
	34510039	0	Plecash AR, Byrne D, Flexman A, et al. Stroke in Patients with Left Ventricular Assist Devices. Cerebrovasc Dis. 2021 Sep 10:1-11. doi: 10.1159/000517454.
	34213527	0	Sanchez van Kammen M, Heldner MR, Brodard J, et al. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA. 2021 Jul 27;326(4):332-338. doi: 10.1001/jama.2021.9889.
	33639297	0	Healey JS, Roberts JD, Field TS. Who is at risk of atrial fibrillation? Heart Rhythm. 2021 Jun;18(6):853-854. doi: 10.1016/j.hrthm.2021.02.019. Epub 2021 Feb 24.
	33074284	0	Shoamanesh A, Hart RG, Connolly SJ, et al. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol. 2021 Jan 1;78(1):11-20. doi: 10.1001/jamaneurol.2020.3836.
	32576089	0	Lu N, Smith JMC, Andrade JG, et al. Considerations in Adult Congenital Heart Disease and Stroke: A Case Report. Stroke. 2020 Aug;51(8):e148-e150. doi: 10.1161/STROKEAHA.119.028605. Epub 2020 Jun 24.
	32369855	0	Giustozzi M, Curcio A, Weijs B, et al. Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. 2020 May;120(5):847-856. doi: 10.1055/s-0040-1709527. Epub 2020 May 5.
	32098609	0	Butcher KS, Ng K, Sheridan P, et al. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. Stroke. 2020 Apr;51(4):1190-1198. doi: 10.1161/STROKEAHA.119.027569. Epub 2020 Feb 26.
	31809335	0	Healey JS, Amit G, Field TS. Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? Curr Opin Neurol. 2020 Feb;33(1):17-23. doi: 10.1097/WCO.0000000000000780.
	31186132	0	Field TS. Recurrent venous thromboembolism after cerebral venous thrombosis: which lower-risk survivors are at risk for recurrence? Thromb Res. 2019 Oct;182:182-183. doi: 10.1016/j.thromres.2019.05.015. Epub 2019 May 31.
	31092159	0	Field TS, Hill MD. Cerebral Venous Thrombosis. Stroke. 2019 Jun;50(6):1598-1604. doi: 10.1161/STROKEAHA.119.025334. Epub 2019 May 16.
	30919384	0	Field TS, Weijs B, Curcio A, et al. Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. 2019 Jun;119(6):981-991. doi: 10.1055/s-0039-1683429. Epub 2019 Mar 27.
	29574430	0	Funnell C, Heran MKS, Teal P, et al. Rapidly expanding venous intracerebral haemorrhage with spot sign. BMJ Case Rep. 2018 Mar 23;2018. pii: bcr-2017-223055. doi: 10.1136/bcr-2017-223055.
	28585903	0	Ng KH, Sharma M, Benavente O, et al. Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II). Int J Stroke. 2017 Oct;12(8):910-914. doi: 10.1177/1747493017711947. Epub 2017 Jun 6.
	27809948	0	Field TS, Camden MC, Al-Shimemeri S, et al. Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologist and Hematologist Respondents in a Canadian Survey. Can J Neurol Sci. 2017 Jan;44(1):116-119. doi: 10.1017/cjn.2016.297. Epub 2016 Nov 4.
	26763915	0	Field TS, Camden MC, Al-Shimemeri S, et al. Off-label use of novel anticoagulants for treatment of cerebral venous thrombosis: A Canadian survey. Int J Stroke. 2017 Dec;12(9):NP16-NP18. doi: 10.1177/1747493015616643. Epub 2016 Jan 12.
	25883570	0	Andrade JG, Field T, Khairy P. Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress. Front Physiol. 2015 Apr 1;6:100. doi: 10.3389/fphys.2015.00100. eCollection 2015.